BMO Capital reiterated an Outperform rating and $39.00 price target on Pfizer (NYSE: PFE) following the company's announcement the merger ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Pfizer (PFE) Pushes Higher after Ending Allergan Deal; Shares Cross Above 200 DMAApril 6, 2016 12:35 PM Pre-Open Stock Movers 04/06: (PLCM) (AYI) (SRPT) Higher; (CREE) (TROX) (MAT) Lower (more...)April 6, 2016 9:29 AM Standalone Allergan (AGN) Could Be Worth $300 - RBC April 6, 2016 8:36 AM Wall Street set for higher open as oil reboundsApril 6, 2016 7:40 AM Pfizer, Allergan scrap $160 billion deal after U.S. tax rule changeApril 6, 2016 6:53 AM Allergan (AGN) Affirms Termination of Pfizer (PFE) Merger; Affirms Strength as Standalone CompanyApril 6, 2016 6:47 AM Pfizer (PFE) Announces Termination of Merger Agreement with Allergan (AGN)April 6, 2016 6:45 AM Allergan Reiterates Strong Standalone Growth Profile and Strategy Following Termination of Pfizer TransactionApril 6, 2016 6:45 AM Pfizer Announces Termination of Proposed Combination with AllerganApril 6, 2016 6:45 AM Deja vu for Paulson as Allergan loss hurts U.S. hedge fundsApril 5, 2016 9:13 PM After-Hours Stock Movers 04/05: (PLCM) (PFE) (AMGN) Higher; (CREE) (LINE) (WYNN) Lower (more...)April 5, 2016 6:02 PM Pfizer (PFE) Announces FDA Approval for INFLECTRA (Biosimilar Infliximab)April 5, 2016 5:35 PM FDA Approves INFLECTRA™ (Biosimilar Infliximab), The First U.S. Biosimilar Monoclonal Antibody, For All Eligible IndicationsApril 5, 2016 5:34 PM FDA Approves Remicade Biosimilar, Inflectra (PFE) (JNJ_April 5, 2016 4:02 PM Allergan (AGN) Could Move on Valeant's (VRX) Bausch + Lomb Unit if Pfizer (PFE) Deal Fails - AnalystApril 5, 2016 3:47 PM Allergen's (AGN) Stand-Alone Price Target is $282 at Deutsche BankApril 5, 2016 3:45 PM Exclusive: Pfizer leaning toward abandoning deal with Allergan - sourceApril 5, 2016 1:55 PM UPDATE: Pfizer (PFE) Examining Ways to Save Allergan (AGN) Deal - BloombergApril 5, 2016 1:48 PM Pfizer (PFE) leaning toward abandoning deal with Allergan (AGN) - ReutersApril 5, 2016 1:41 PM Most Important Data Point Going Foward in AGN/PFE Deal Will Be Path Forward Pfizer (PFE) Chooses - RBCApril 5, 2016 1:12 PM Obama urges Congress to take action on corporate tax reformApril 5, 2016 12:46 PM President Obama to speak on inversions at 12:15PMApril 5, 2016 11:08 AM Pfizer (PFE), Allergan (AGN) deal appears likely to be dead - CNBC's FaberApril 5, 2016 10:05 AM Remedy Pharmaceuticals Appoints Dr. Thomas R. Zimmerman Jr. as Vice President, Medical AffairsApril 5, 2016 9:30 AM Pre-Open Stock Movers 04/05: (VRX) (MRVL) (ICPT) Higher; (PSUN) (AGN) (NATI) Lower (more...)April 5, 2016 9:26 AM Pfizer (PFE), Merck (MRK) Treat First Patient in Avelumab Phase 3April 5, 2016 8:22 AM Pfizer (PFE), Merck KGaA Treat First Patient in Avelumab Phase 3 in RCC SettingApril 5, 2016 8:10 AM Merck and Pfizer Announce First Patient Treated in Phase III Combination Study with Avelumab and INLYTA® in Renal Cell CarcinomaApril 5, 2016 8:03 AM Merck KGaA, Darmstadt, Germany, and Pfizer Announce First Patient Treated in Phase III Combination Study with Avelumab and INLYTA® in Renal Cell CarcinomaApril 5, 2016 8:02 AM After rally, earnings gloom takes hold on Wall StreetApril 5, 2016 7:32 AM Treasury Action More than a Wrinkle for Pfizer (PFE)/Allergan (AGN) Deal - JefferiesApril 5, 2016 7:19 AM Pfizer (PFE) Announces Tofacitinib Phase 3 Met Primary Efficacy Endpoints in Psoriatic ArthritisApril 5, 2016 7:04 AM Pfizer Announces Positive Top-Line Results from the First Phase 3 Trial of Investigational Tofacitinib in Adults with Psoriatic ArthritisApril 5, 2016 7:00 AM New Treasury Action Could Block, or Significantly Change Pfizer (PFE)/Allergan (AGN) Deal - BMO CapitalApril 5, 2016 6:53 AM Allergen (AGN) Trading Below Standalone Value Following New Treasury Action - RBCApril 5, 2016 6:42 AM Allergan (AGN), Pfizer (PFE) Comment on U.S. Treasury Action; Won't Comment on Potential ImpactApril 5, 2016 6:37 AM Dollar touches 17-month low vs. yen as stocks slumpApril 4, 2016 8:23 PM Pfizer and Allergan Issue StatementApril 4, 2016 7:05 PM After-Hours Stock Movers 04/04: (PFE) Higher; (PSUN) (AGN) (TSLA) Lower (more...)April 4, 2016 6:15 PM Pfizer (PFE) Conducting Review of U.S. Treasury Notice, Won't Speculate on Potential Effect - Bloomberg, Citing SpokeswomanApril 4, 2016 5:53 PM Allergan (AGN) Slammed on New U.S. Treasury Inversion Action; Pfizer (PFE) HigherApril 4, 2016 5:24 PM Cancer Metabolism Company Metabomed Completes $18 Million Series A FinancingApril 4, 2016 9:01 AM Wall Street pulls back after recent rallyApril 4, 2016 7:24 AM